Page last updated: 2024-09-05

erlotinib and honokiol

erlotinib has been researched along with honokiol in 2 studies

Compound Research Comparison

Studies
(erlotinib)
Trials
(erlotinib)
Recent Studies (post-2010)
(erlotinib)
Studies
(honokiol)
Trials
(honokiol)
Recent Studies (post-2010) (honokiol)
22101808161586

Protein Interaction Comparison

ProteinTaxonomyerlotinib (IC50)honokiol (IC50)
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))1.39
TPA: protein transporter TIM10Saccharomyces cerevisiae S288C48.8
high affinity choline transporter 1 isoform aHomo sapiens (human)12.0226
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)4.2
Prostaglandin G/H synthase 2Ovis aries (sheep)2.1

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Reviews

1 review(s) available for erlotinib and honokiol

ArticleYear
Recent update on anti-dengue drug discovery.
    European journal of medicinal chemistry, 2019, Aug-15, Volume: 176

    Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication

2019

Other Studies

1 other study(ies) available for erlotinib and honokiol

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023